HERmesa

HERmesa is a London-based angel syndicate dedicated to backing female founders, with frequent investment activity in women’s health, reproductive health, and digital health and wellness more broadly. The syndicate aggregates angel investors who collectively support early-stage companies founded by women, providing both capital and an active community of operator and investor mentors. Its thematic concentration on women’s health reflects both founder demographics and the syndicate’s view that the category remains structurally underfunded. HERmesa is not framed as an AI-specific investor, and limited public information is available about specific named lead members or partners.

HERmesa invests at Pre-Seed and Seed stages, with aggregate syndicate checks below $250k, sized to participate in early angel rounds rather than lead institutional priced rounds. Geographic focus centers on the United Kingdom and broader European female-founded companies, with sourcing extending across the syndicate’s member networks. The group commonly co-invests with UK angel networks, dedicated women’s health funds, and early-stage venture firms.

For female founders building women’s health, reproductive health, or broader digital health companies, HERmesa offers both early capital and a network of women operators and investors who can provide warm introductions and category-specific advice. Founders should expect engagement with multiple individual angel members rather than a single decision-making partner, and a process tuned to early company formation. The syndicate is not the right fit for capital-intensive biotech, late-stage rounds, or companies whose founding teams do not include women. For female founders at the earliest stage of women’s health innovation, HERmesa is a meaningful UK ecosystem participant.